Stressed out by U.S. election? Tune out and assume downward-facing dog pose

WASHINGTON (Reuters) - Stop reading the news and take up yoga. That's what some therapists in the United States are telling patients stressed out by a nasty presidential campaign in which two unpopular candidates are in a tight race for the most powerful office in the world.

Big Pharma vs Big Pharma in court battles over biosimilar drugs

ZURICH (Reuters) - The line dividing makers of brand-name drugs and copycat medicines is blurring as companies known for innovative treatments queue up to peddle copies of rivals' complex biological medicines.

Morphosys moves closer to getting first antibody drug on market

FRANKFURT (Reuters) - German biotech Morphosys moved a step closer to getting its first antibody drug onto the market as its licensee, Johnson & Johnson unit Jenssen, reported positive results from a phase 3 study of psoriasis drug guselkumab.